Susan Hasty, Publisher
Table of Contents . . . July 26th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Drug Law Weekly | Other Publications
Chemokine Therapeutics Corp. - U.S. patent allowed for novel cancer drug in clinical development
Frost & Sullivan - Consultancy releases study on pharma industry
Generex Biotechnology Corp. - Drug-delivery company gets Mexican patent
Hacettepe University, Ankara - N-acetylcysteine treatment has no prophylactic use
Medtronic, Inc. - Technology company purchases land for new headquarters, launches online resource
Myriad Genetics, Inc. - Biopharmaceutical company announces patent on amyloid lowering drugs
National Prostate Cancer Coalition - ED drug amendment passage puts lives at risk, says prostate cancer organization
NeighborCare, Inc. - Medicare Part D prescription drug benefit agreement announced
Progenics Pharmaceuticals, Inc. - Pharma company hires Sr. VP and general counsel, announces promotion
Richardson, Patrick, Westbrook & Brickman, LLC - Eli Lilly & Co. to pay $700 million in product liability group settlement
State Government of Victoria, Australia - Australian officials launch new human embryonic stem cell line, drives network
Swinburne University of Technology - Standardized Field Sobriety Tests detect marijuana intoxication
University of Minnesota - Long-term benefits of Aldara cream for actinic keratosis reported
XOMA Ltd - License agreement with Merck entered for use of bacterial cell expression
Adenosine Therapeutics, LLC - Pharmaceutical company announces personnel changes
Am. Soc. of Health-System Pharmacists - Aspirin underprescribed to prevent heart attack and stroke
American Diabetes Association - Diabetes group urges Senate action on stem cell research legislation
American Specialty Health - Oregon health plan offers chiropractic, acupuncture, and massage benefits
Aristotle University of Thessaloniki - Invisalign system provides aesthetic treatment option
Austin Research Institute - Insights into peptide-based vaccine design for cancer therapy presented
Azienda Ospedale San Salvatore, Pesaro - Gastric cancer management strategies recommended
BC Center for Excellence in HIV/AIDS, Vancouver - New findings in the area of HIV/AIDS therapy described
Bayer HealthCare, LLC. - Phase I trial to begin for Kogenate hemophilia product
Baylor College of Medicine, Houston - Peripheral blood cell fractions spawn endothelial progenitor cells
BioMarin Pharmaceutical, Inc. - Naglazyme for MPS VI launched in U.S.
Biosite Incorporated - Biomedical company adds two VPs to executive management
Boehringer Ingelheim - New pramipexole data for restless leg syndrome presented at conference
Boehringer Ingelheim - Prolonged-release tamsulosin tablet for benign prostatic hyperplasia launched
Boston Medical Center - Safety of oxcarbazepine investigated
Brigham & Women's Hospital, Boston - Researchers publish new studies and findings in the area of cardiology
Business Update - American Healthways receives high marks on NCQA review
Capital Health-Public Health Division, Edmonton - E. coli O157:H7 colitis outbreak associated with unpasteurized gouda cheese
Centenary Institute of Cancer - Sensitivity of assays for detecting tuberculosis compared
Charite University of Medicine Berlin - Drugs and therapy prevent interferon-induced depression in high-risk patients
Charite-Universitatsmedizin Berlin - Noncanonical melanoma T cell epitopes identified for cancer therapy
Children's Hospital Boston - Urine test may help monitor disfiguring birthmarks
Children's Hospital of Pittsburgh - Study finds adult stem cells show same ability to self-renew as embryonic
Chiron Vaccines - HIV gag-specific gamma interferon-expressing cells characterized
Cleveland Clinic Foundation - CED drug delivery technique reviewed
Columbia University, New York - Data: Patients on Concerta more likely to continue with long-term therapy
Cornell University - Transforming growth factor-beta I gene therapy restores beta cell function
DURECT Corp. - Preliminary results announced from study of postoperative pain relief product
DataLabs - Company launches single data management system
Elan Corporation - Phase 3 induction trial in Crohn disease therapy meets primary endpoint
Emergent BioSolutions, Inc. - Microscience, a U.K.-based vaccine company, acquired
Entelos, Inc. - Biosimulation company presents type 1 diabetes model and scientific insights
Eyetech Pharmaceuticals, Inc. - Company raises sales forecast for Macugen (pegaptanib sodium injection)
Fed. Armed Forces Inst. of Microbiology, Munich - Real-time PCR assay enables rapid, accurate diagnosis
FlowMedica - First patient receives TRT with Benephit Delta Infusion System
Forbes Medi-Tech, Inc. - FM-VP4 toxicity study complete
Fred Hutchinson Cancer Research Center - Dendritic cells efficiently cross-prime tumor antigen-specific T cells
Genaera Corp. - Company completes SPA with FDA for EVIZON in AMD
GlaxoSmithKline - Reports advance knowledge in statins research
Harefield Hospital - Renal function, compliance are long-term complicating factors in children
Harokopio University, Athens - Anti-inflammatory effect may help explain fish benefit
Harvard University - Resistin levels decrease after rosiglitazone in HIV patients with lipoatrophy
J. Craig Venter Institute - New 15-month policy study of risks and benefits of synthetic genomics set
Migenix Inc. - U.S. FDA, research company sign protocol for trial of catheter-linked infections
NJ Stem Cell Research & Education Foundation - Collaborative stem cell partnership announced in New Jersey
New River Pharmaceuticals Inc. - Pharma compoany files investigational new drug application for pain treatment
NxStage Medical, Inc. - Portable daily hemodialysis device receives U.S. FDA clearance
Perrigo Company - Pharma company announces approval for Orange Ibuprofen Tablets
Questcor Pharmaceuticals, Inc. - U.S. FDA approves Acthar API manufacturing transfer
Santarus, Inc. - FDA accepts NDA for ZEGERID
Sucampo Pharmaceuticals, Inc. - Tacrolimus eye drops study halted, complaint filed against business partner
Teva Pharmaceutical Industries Ltd. - IND submitted to U.S. FDA for oral treatment of relapsing multiple sclerosis
ThermoGenesis Corp. - Enrollment in trial of new fibrin sealant system for liver transplant complete
U.S. Centers for Disease Control & Prevention - Measles control is possible in areas of widespread HIV infection
U.S. Food & Drug Administration - Beta-chemokines induced by orthophosphorothioate oligodeoxynucleotides
U.S. Food & Drug Administration - New tyrosine phosphorylation site in phospholipase-C-gamma-1 identified
U.S. Food & Drug Administration - Vail Products issues nationwide recall of enclosed bed systems
UCB Pharma, Inc. - U.S. FDA approves Keppra for use in childhood epilepsy
Univ. of California, Los Angeles - Scientists discover how Nipah virus enters cells
Washington University, St. Louis - Antibiotic nonadherence is a concern for future bioterrorist events
Wildlife Conservation Society - Controlling wildlife trade key to preventing health crises
diaDexus, Inc. - U.S. FDA grants clearance to market blood test for assessing risk of stroke
eResearchTechnology, Inc. - Agreement signed to deliver cardiac safety services to Japanese trial market
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.